HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hepatic inflammation elicits production of proinflammatory netrin-1 through exclusive activation of translation.

AbstractBACKGROUND AND AIMS:
Netrin-1 displays protumoral properties, though the pathological contexts and processes involved in its induction remain understudied. The liver is a major model of inflammation-associated cancer development, leading to HCC.
APPROACH AND RESULTS:
A panel of cell biology and biochemistry approaches (reverse transcription quantitative polymerase chain reaction, reporter assays, run-on, polysome fractionation, cross linking immunoprecipitation, filter binding assay, subcellular fractionation, western blotting, immunoprecipitation, stable isotope labeling by amino acids in cell culture) on in vitro-grown primary hepatocytes, human liver cell lines, mouse samples and clinical samples was used. We identify netrin-1 as a hepatic inflammation-inducible factor and decipher its mode of activation through an exhaustive eliminative approach. We show that netrin-1 up-regulation relies on a hitherto unknown mode of induction, namely its exclusive translational activation. This process includes the transfer of NTN1 (netrin-1) mRNA to the endoplasmic reticulum and the direct interaction between the Staufen-1 protein and this transcript as well as netrin-1 mobilization from its cell-bound form. Finally, we explore the impact of a phase 2 clinical trial-tested humanized anti-netrin-1 antibody (NP137) in two distinct, toll-like receptor (TLR) 2/TLR3/TLR6-dependent, hepatic inflammatory mouse settings. We observe a clear anti-inflammatory activity indicating the proinflammatory impact of netrin-1 on several chemokines and Ly6C+ macrophages.
CONCLUSIONS:
These results identify netrin-1 as an inflammation-inducible factor in the liver through an atypical mechanism as well as its contribution to hepatic inflammation.
AuthorsRomain Barnault, Claire Verzeroli, Carole Fournier, Maud Michelet, Anna Rita Redavid, Ievgeniia Chicherova, Marie-Laure Plissonnier, Annie Adrait, Olga Khomich, Fleur Chapus, Mathieu Richaud, Maëva Hervieu, Veronika Reiterer, Federica Grazia Centonze, Julie Lucifora, Birke Bartosch, Michel Rivoire, Hesso Farhan, Yohann Couté, Valbona Mirakaj, Thomas Decaens, Patrick Mehlen, Benjamin Gibert, Fabien Zoulim, Romain Parent
JournalHepatology (Baltimore, Md.) (Hepatology) Vol. 76 Issue 5 Pg. 1345-1359 (11 2022) ISSN: 1527-3350 [Electronic] United States
PMID35253915 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2022 American Association for the Study of Liver Diseases.
Chemical References
  • Toll-Like Receptor 2
  • Nerve Growth Factors
  • Toll-Like Receptor 3
  • Toll-Like Receptor 6
  • Tumor Suppressor Proteins
  • Anti-Inflammatory Agents
  • RNA, Messenger
  • Amino Acids
  • Netrin Receptors
Topics
  • Mice
  • Humans
  • Animals
  • Toll-Like Receptor 2
  • Nerve Growth Factors (metabolism)
  • Carcinoma, Hepatocellular
  • Toll-Like Receptor 3
  • Toll-Like Receptor 6
  • Tumor Suppressor Proteins (metabolism)
  • Liver Neoplasms
  • Inflammation (metabolism)
  • Anti-Inflammatory Agents
  • RNA, Messenger
  • Amino Acids
  • Netrin Receptors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: